Clinical trial disclosure
Clinical trial disclosure sits at the intersection of securities law and biotech finance, and Financial & Capital Markets firms with exposure to life sciences issuers are operating under active scrutiny from the U.S. Securities and Exchange Commission, which has used Rule 10b-5 and Regulation FD enforcement actions to press hard on selective disclosure of trial data that moves prices. The European Securities and Markets Authority has added pressure through its market abuse framework, particularly where clinical readouts qualify as inside information under MAR Article 7. Compliance teams are not waiting: many are now pre-clearing trial milestone communications against their material nonpublic information policies before investor calls.
Watch
- SEC Rule 10b-5 enforcement pattern around undisclosed Phase III trial failures
- MAR Article 7 threshold: when a trial endpoint becomes inside information
- Regulation FD selective disclosure risk on clinical data shared with analysts pre-announcement
- FINRA suitability review of structured products tied to clinical-stage biotech performance
Recent material activity in Financial & Capital Markets
-
SEC seeks public comment on extending Rule 13f-2 short position reporting collection under institutional investment manager regime
The SEC published a proposed collection extension notice on July 27, 2026 for the information collection requirements under Rule 13f-2, which governs short position and short activity reporting by institutional investmen…
Read a full sample brief → -
RBI extends supervisory directions over Sonpeth Nagari Sahakari Bank Maryadit by three months to October 30, 2026
The Reserve Bank of India has extended its binding supervisory directions over Sonpeth Nagari Sahakari Bank Maryadit, Sonpeth, Maharashtra. The extension runs from July 30, 2026 to October 30, 2026, subject to review, wi…
Read a full sample brief → -
RBI extends supervisory directions over Irinjalakuda Town Co-operative Bank by three months to October 30, 2026
The Reserve Bank of India extended its supervisory directions over The Irinjalakuda Town Co-operative Bank Ltd., Kerala on July 24, 2026. The extension runs three months, from close of business on July 30, 2026 to close …
Read a full sample brief → -
SEBI issues final quasi-judicial order against front-running of Axis Mutual Fund trades
SEBI's Enforcement Division issued a final order on July 24, 2026 concluding proceedings against parties who front-ran trades of Axis Mutual Fund. The order resolves a named enforcement action and establishes a concluded…
Read a full sample brief → -
SEBI issues ex parte interim order against Stark Investments and associates for unregistered investment advisory and portfolio management operations
SEBI issued an ex parte interim order on July 24, 2026 against Stark Investments and associated persons for conducting unregistered investment advisory and portfolio management services. The order reflects SEBI's sustain…
Read a full sample brief → -
SEBI issues quasi-judicial enforcement order against Nalwa Sons Investments Limited
SEBI's Enforcement Division issued a quasi-judicial order on July 24, 2026 against Nalwa Sons Investments Limited. The specific findings, charges, and remedial directions are not disclosed in the available source text.
Read a full sample brief → -
SEBI issues quasi-judicial enforcement order against Hexa Tradex Limited
SEBI's Enforcement Division issued a quasi-judicial order against Hexa Tradex Limited on July 24, 2026. The order originates from SEBI's enforcement directorate, confirming a formal adjudicatory proceeding against the na…
Read a full sample brief → -
SEBI issues final order against Madhav Stock Vision and associates for front-running violations
On July 24, 2026, SEBI's Chairperson or a Member issued a final order against Madhav Stock Vision Pvt. Ltd. and associated parties for front-running conduct. The order concludes an enforcement proceeding and carries bind…
Read a full sample brief → -
SFC issues binding circular restructuring compliance baseline for listed structured funds in Hong Kong
On July 24, 2026, the Securities and Futures Commission issued a circular setting out conduct, disclosure, and structural requirements for listed structured funds operating in Hong Kong.
Read a full sample brief → -
SFC reprimands and fines Victory Securities $1.7 million for AML and supervision failures, suspends responsible officer
On July 24, 2026, the Securities and Futures Commission reprimanded Victory Securities Company Limited and imposed a HK$1.7 million fine for regulatory breaches. The action also suspends a responsible officer, reflecting…
Read a full sample brief →